InvestorsHub Logo
Followers 0
Posts 56
Boards Moderated 0
Alias Born 12/12/2014

Re: dr_lowenstein post# 31987

Wednesday, 08/05/2015 12:44:59 AM

Wednesday, August 05, 2015 12:44:59 AM

Post# of 48316
Good question. For whatever you intend to use the data. A sample size of 1 in September as you so eloquently mention can be statistically significant for the investment community to decide to heavily invest in ONCS or to flee. It depends on what that sample size of 1 shows. If it was shown that the combination is toxic and caused death after 2 days I think that would be statistically significant to cause investors to flee. If the sample size of 1 showed complete regression of all tumors in all locations on the body I think that would cause dramatic investment. Statistically relevant from a FDA or traditional definition... no, nonetheless statistically relevant from an investing viewpoint.